Role of intestinal microbiota in transplantation outcomes.


Por: Taur Y, Jenq RR, Ubeda C, van den Brink M and Pamer EG

Fecha de Publicación: 01/06/2015
Resumen:
While allogeneic hematopoietic stem cell transplantations have a curative potential, infections and graft-versus-host disease remain significant problems. The intestinal microbiota can influence responses to cancer chemotherapy and the role of the microbiota in affecting allogeneic hematopoietic stem cell transplantation outcomes is increasingly appreciated. The following paper discusses the most recent developments in this area.

Direcciones
Taur Y: Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York
Jenq RR: Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York
Ubeda C: Centro Superior de Investigacion en Salud Publica-FISABIO, Valencia, Spain
van den Brink M: Division of Hematologic Oncology, Alan N. Houghton Chair, Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York
Pamer EG: Weill Cornell Medical College, New York; Division of General Medicine, Chief, Infectious Diseases Service, Enid A. Haupt Chair in Clinical Investigation, Memorial Sloan Kettering Cancer Center, New York, NY, USA
ISSN: 15216926





BEST PRACT RES CL HA
Editorial
Bailliere Tindall Ltd, Reino Unido
Tipo de documento: Article
Volumen: 28 Número: 2-3
Páginas: 155-161s
WOS: 000366074300013
ID de PubMed: 26590773

MÉTRICAS